FDA Approves Gilead’s ‘Quad’ Combo Pill for HIV Treatment

Drug Industry Daily
A A
The FDA has approved Gilead’s Stribild, previously called Quad, as a once-daily combo pill for treatment-naïve adults with HIV.

To View This Article:

Login

Subscribe To Drug Industry Daily